These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16943596)

  • 1. Plasma paraoxonase activities, lipoprotein oxidation, and trace element interaction in asthmatic patients.
    Ekmekci OB; Donma O; Ekmekci H; Yildirim N; Uysal O; Sardogan E; Demirel H; Demir T
    Biol Trace Elem Res; 2006; 111(1-3):41-52. PubMed ID: 16943596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
    Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
    Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.
    Göçmen AY; Gümüşlü S; Semiz E
    Clin Cardiol; 2004 Jul; 27(7):426-30. PubMed ID: 15298047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma paraoxonase 1 arylesterase activity in D-galactose-induced aged rat model: correlation with LDL oxidation and redox status.
    Kumar D; Rizvi SI
    Aging Clin Exp Res; 2014 Jun; 26(3):261-7. PubMed ID: 24214524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma paraoxonase-1, oxidized low-density lipoprotein and lipid peroxidation levels in gout patients.
    Jiang XL; Li M; Zhou JG; Yang QB; Du LJ; Du J
    Cell Biochem Biophys; 2011 Nov; 61(2):461-6. PubMed ID: 21748243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants.
    Aviram M; Rosenblat M; Billecke S; Erogul J; Sorenson R; Bisgaier CL; Newton RS; La Du B
    Free Radic Biol Med; 1999 Apr; 26(7-8):892-904. PubMed ID: 10232833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidant status in blood of obese children: the relation between trace elements, paraoxonase, and arylesterase values.
    Cayir Y; Cayir A; Turan MI; Kurt N; Kara M; Laloglu E; Ciftel M; Yildirim A
    Biol Trace Elem Res; 2014 Aug; 160(2):155-60. PubMed ID: 24920129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraoxonase 1 activity and level of antibodies directed against oxidized low density lipoproteins in a group of an elderly population in Poland - PolSenior study.
    Bednarska-Makaruk M; Rodo M; Szirkowiec W; Mossakowska M; Puzianowska-Kuźnicka M; Skalska A; Zdrojewski T; Ryglewicz D; Wehr H
    Arch Gerontol Geriatr; 2015; 60(1):153-61. PubMed ID: 25459919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum paraoxonase phenotype distribution in exudative age-related macular degeneration and its relationship to homocysteine and oxidized low-density lipoprotein.
    Javadzadeh A; Ghorbanihaghjo A; Bahreini E; Rashtchizadeh N; Argani H; Alizadeh S
    Retina; 2012 Apr; 32(4):658-66. PubMed ID: 22030834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum oxidized low density lipoprotein, paraoxonase 1 and lipid peroxidation levels during oral glucose tolerance test.
    Serin O; Konukoglu D; Firtina S; Mavis O
    Horm Metab Res; 2007 Mar; 39(3):207-11. PubMed ID: 17373636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of plasma oxidized low-density lipoprotein levels to vascular complications and human serum paraoxonase in patients with type 2 diabetes.
    Tsuzura S; Ikeda Y; Suehiro T; Ota K; Osaki F; Arii K; Kumon Y; Hashimoto K
    Metabolism; 2004 Mar; 53(3):297-302. PubMed ID: 15015140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher Levels of Oxidized Low Density Lipoproteins in Alzheimer's Disease Patients: Roles for Platelet Activating Factor Acetyl Hydrolase and Paraoxonase-1.
    Bacchetti T; Vignini A; Giulietti A; Nanetti L; Provinciali L; Luzzi S; Mazzanti L; Ferretti G
    J Alzheimers Dis; 2015; 46(1):179-86. PubMed ID: 25720407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypochlorous acid and low serum paraoxonase activity in haemodialysis patients: an in vitro study.
    Sutherland WH; de Jong SA; Walker RJ
    Nephrol Dial Transplant; 2004 Jan; 19(1):75-82. PubMed ID: 14671042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal cortical thickness and PON1 activity both decrease in chronic renal failure.
    Ak G; Ozgönül M; Sözmen EY; Aslan SL; Sözmen B
    J Nephrol; 2002; 15(2):144-9. PubMed ID: 12018630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased oxidized-LDL levels and arylesterase activity/HDL ratio in ESRD patients treated with hemodialysis.
    Mahrooz A; Zargari M; Sedighi O; Shaygani H; Gohari G
    Clin Invest Med; 2012 Jun; 35(3):E144-51. PubMed ID: 22673317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human plasma paraoxonase 1 (PON1) arylesterase activity during aging: correlation with susceptibility of LDL oxidation.
    Mehdi MM; Rizvi SI
    Arch Med Res; 2012 Aug; 43(6):438-43. PubMed ID: 22959975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PON1, a new biomarker of cardiovascular disease, is low in patients with systemic vasculitis.
    Quéméneur T; Martin-Nizard F; Kandoussi A; Kyndt X; Vanhille P; Hachulla E; Hatron PY; Fruchart JC; Duriez P; Lambert M
    Semin Arthritis Rheum; 2007 Dec; 37(3):149-55. PubMed ID: 17512573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LDL density and oxidation are modulated by PON1 promoter genotype in patients with Alzheimer's disease.
    Cagnin A; Leon A; Vianello D; Colavito D; Favaretto S; Zarantonello G; Stecca A; Ermani M; Zambon A
    J Alzheimers Dis; 2013; 34(2):377-85. PubMed ID: 23207490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between serum paraoxonase activity and oxidative stress in acute coronary syndromes.
    Kabaroglu C; Mutaf I; Boydak B; Ozmen D; Habif S; Erdener D; Parildar Z; Bayindir O
    Acta Cardiol; 2004 Dec; 59(6):606-11. PubMed ID: 15636443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraoxonase, a cardioprotective enzyme: continuing issues.
    Getz GS; Reardon CA
    Curr Opin Lipidol; 2004 Jun; 15(3):261-7. PubMed ID: 15166781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.